Q3 FY2026
Filed Nov 4, 20263D Systems Reports Third Quarter 2026 Financial Results
Revenue, gross margin and Adjusted EBITDA improved, with Adjusted EBITDA turning positive, but the Company reported a wider net loss, negative operating cash flow for the first nine months, and guided to Adjusted EBITDA of ($2) million - $0 million in the fourth quarter.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Q3 2026 total revenueGAAP | $99.3M | – | 8.8% |
| Q3 2026 products revenueGAAP | $58,178 | – | – |
| Q3 2026 services revenueGAAP | $41,126 | – | – |
| Q3 2026 revenue excluding software divestituresnon-GAAP | $99.3M | – | 10.9% |
| Q3 2026 gross profitGAAP | $34.8M | – | – |
| Q3 2026 gross profit marginGAAP | 35.0% | – | – |
| Q3 2026 non-GAAP gross profitnon-GAAP | $35.2M | – | – |
| Q3 2026 non-GAAP gross profit marginnon-GAAP | 35.5% | – | – |
| Q3 2026 non-GAAP gross profit margin excluding software divestituresnon-GAAP | 35.5% | – | 420 basis points |
| Q3 2026 operating expensesGAAP | $59.3M | – | – |
| Q3 2026 non-GAAP operating expenses excluding software divestituresnon-GAAP | $36.1M | – | – |
| Q3 2026 operating lossGAAP | −$24.5M | – | – |
| Q3 2026 net loss attributable to 3D Systems CorporationGAAP | −$33.5M | – | increased by $15.5 million |
| Q3 2026 diluted loss per shareGAAP | $(0.21) | – | – |
| Q3 2026 non-GAAP diluted loss per share excluding software divestituresnon-GAAP | $(0.06) | – | – |
| Q3 2026 Adjusted EBITDAnon-GAAP | $3.1M | – | – |
| Q3 2026 Adjusted EBITDA excluding software divestituresnon-GAAP | $3.1M | – | improved $13.1 million |
| Nine months 2026 total revenueGAAP | $289.4M | – | – |
| Nine months 2026 products revenueGAAP | $170,788 | – | – |
| Nine months 2026 services revenueGAAP | $118,633 | – | – |
| Nine months 2026 revenue excluding software divestituresnon-GAAP | $289.4M | – | – |
| Nine months 2026 gross profitGAAP | $103.6M | – | – |
| Nine months 2026 gross profit marginGAAP | 35.8% | – | – |
| Nine months 2026 non-GAAP gross profit margin excluding software divestituresnon-GAAP | 36.1% | – | – |
| Nine months 2026 operating expensesGAAP | $145.4M | – | – |
| Nine months 2026 non-GAAP operating expenses excluding software divestituresnon-GAAP | $112.2M | – | – |
| Nine months 2026 operating lossGAAP | −$41.8M | – | – |
| Nine months 2026 net loss attributable to 3D Systems CorporationGAAP | −$50.8M | – | – |
| Nine months 2026 diluted loss per shareGAAP | $(0.33) | – | – |
| Nine months 2026 non-GAAP diluted loss per share excluding software divestituresnon-GAAP | $(0.11) | – | – |
| Nine months 2026 Adjusted EBITDA excluding software divestituresnon-GAAP | $4.4M | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Q3 2026 Healthcare SolutionsHigher dental material sales and increased parts manufacturing volumes. | $49M | – | approximately 14.4% |
| Q3 2026 Industrial SolutionsHigher printer and parts manufacturing sales; revenue increased 7.7% excluding the impact of software divestitures. | $50.3M | – | approximately 3.9% |
| Nine months 2026 Healthcare SolutionsThe Company said its four strategic markets delivered strong double-digit growth through the first three quarters of 2026. | $147.2M | – | – |
| Nine months 2026 Industrial SolutionsThe Company said its four strategic markets delivered strong double-digit growth through the first three quarters of 2026. | $142.2M | – | – |
Fourth Quarter 2026 outlook
- Revenue$100 - $103 million
- NoteAdjusted EBITDA: ($2) million - $0 million
- NoteAt the midpoint of its fourth-quarter outlook, the Company expects full year revenue growth approaching mid-single digits for 2026.
Capital returns
- Stock repurchases: —
- Proceeds from equity offering: $53,825
- Purchase of non-controlling interests: $(900)
- Taxes paid related to net-share settlement of equity awards: $(879)
What drove it
- Q3 revenue growth was driven by double-digit growth in new printer and parts manufacturing sales and strong dental materials revenue.
- Healthcare growth was driven by continued growth in personalized healthcare solutions, including more than 20% growth in healthcare parts manufacturing and dental materials sales.
- Industrial performance reflected strong growth in Data Center Infrastructure and more than 50% growth in Aerospace & Defense.
- Non-GAAP gross profit margin benefited from higher printer and parts-manufacturing volumes, product gross profit margin expansion, and the non-recurrence of certain prior-year costs associated with a non-core site closure and a Reg Med accounting adjustment.
- Adjusted EBITDA improvement reflected prior cost reduction initiatives, higher sales volumes and improved operating leverage.
Concerns
- Q3 net loss attributable to 3D Systems Corporation was $(33.5) million, compared with $(18.1) million in the prior-year period.
- The increased net loss was primarily attributed to litigation expense, an asset impairment charge, an unfavorable foreign exchange impact, and an unfavorable year-over-year change in income taxes.
- Q3 asset impairment charges were $2,857.
- Q3 foreign exchange loss, net was $(6,294), compared with foreign exchange gain, net of $2,623 in the prior-year period.
- Nine months 2026 net cash used in operating activities was $(17,502).
- The fourth-quarter outlook calls for Adjusted EBITDA of ($2) million - $0 million.
- The outlook incorporates normal variability in customer program and investment cycles and more evenly distributed purchasing patterns observed throughout the year.
- The Company cited a volatile broader economic and geopolitical environment.
What to watch
- Execution against fourth-quarter revenue guidance of $100 - $103 million.
- Whether fourth-quarter Adjusted EBITDA falls within the guided range of ($2) million - $0 million after Q3 Adjusted EBITDA of $3.1 million.
- Continued demand in Med Tech, Dental, Aerospace & Defense and Data Center Infrastructure.
- Customer program and investment-cycle variability and purchasing patterns.
- Cash usage, including operating cash flow and purchases of property and equipment.
- The $3.9 million in principal debt scheduled to mature in the fourth quarter of 2026.
Balance sheet and cash flow
- At September 30, 2026, total cash and investments were $120.5 million.
- Cash, cash equivalents and restricted cash were $91.8 million.
- Short-term investments were $27.1 million.
- Long-term investments were $1.6 million.
- Current portion of long-term debt, net of deferred financing costs, was $3,944.
- Long-term debt, net of deferred financing costs, was $87,852.
- $3.9 million in principal amount of debt is scheduled to mature in the fourth quarter of 2026, with the remaining $92.0 million principal maturing in 2030.
- Nine months 2026 net cash used in operating activities was $(17,502).
- Nine months 2026 purchases of property and equipment were $(8,315).
- Nine months 2026 net cash used in investing activities was $(37,918).
- Nine months 2026 net cash provided by financing activities was $50,108.
- Cash, cash equivalents and restricted cash at the end of the period was $91,766.
Analysis
Third-quarter revenue was $99.3 million, compared with $91.2 million in the prior-year period, with growth led by Healthcare Solutions revenue of $49.0 million and Industrial Solutions revenue of $50.3 million. Healthcare growth was tied to dental materials and parts manufacturing volumes. Industrial growth reflected higher printer and parts manufacturing sales, with Data Center Infrastructure and Aerospace & Defense identified as key contributors. Revenue excluding software divestitures was $99.3 million, compared with $89.5 million in the prior-year period.
Profitability improved at the gross-profit and adjusted EBITDA levels. GAAP gross profit margin was 35.0%, compared with 32.3%, while non-GAAP gross profit margin excluding software divestitures was 35.5%, compared with 31.3%. The Company attributed the improvement to printer and parts-manufacturing volumes, product gross-profit expansion and the absence of specified prior-year costs. Adjusted EBITDA excluding software divestitures was $3.1 million, compared with $(10.0) million, supported by cost actions, higher volume and operating leverage.
GAAP earnings remained pressured. Net loss attributable to 3D Systems Corporation was $(33.5) million, compared with $(18.1) million, and diluted loss per share was $(0.21), compared with $(0.14). Management cited litigation expense, an asset impairment charge, unfavorable foreign exchange and an unfavorable year-over-year change in income taxes. Q3 operating loss was $(24.5) million, compared with $(21.3) million, despite the improvement in non-GAAP operating expenses excluding software divestitures to $36.1 million from $42.3 million.
For the first nine months, revenue was $289.4 million and Adjusted EBITDA excluding software divestitures was $4.4 million, compared with $(40.8) million. However, net cash used in operating activities was $(17,502), and the Company ended the period with total cash and investments of $120.5 million. It also raised $53,825 through an equity offering during the nine-month period.
Fourth-quarter guidance calls for revenue of $100 - $103 million and Adjusted EBITDA of ($2) million - $0 million. Management described continued momentum in its four strategic markets but incorporated customer-program and investment-cycle variability and more evenly distributed purchasing patterns. The guide points to a return to negative or breakeven adjusted EBITDA following the positive third quarter, making demand conversion, operating leverage and cash usage central items for the next report.
Management, verbatim
We are pleased with our third-quarter and year-to-date performance. Revenue growth accelerated, Adjusted EBITDA turned positive for the quarter and the year-to-date period, and our four strategic markets, Med Tech, Dental, Aerospace & Defense, and Data Center Infrastructure, continued to deliver strong double-digit growth.
Dr. Jeffrey Graves, President and Chief Executive Officer of 3D Systems
As the additive manufacturing industry begins to emerge from a multi-year downturn, the consistent investments we have made in technology, application expertise, and production capacity during this challenging period have positioned the Company to benefit from the recovery.
Dr. Jeffrey Graves, President and Chief Executive Officer of 3D Systems
We delivered strong revenue growth while maintaining effective cost management, resulting in positive Adjusted EBITDA year-to-date.
Phyllis Nordstrom, Chief Financial Officer of 3D Systems
Not in the filing
stated, not guessed- Previous-quarter financial metrics and sequential comparisons were not provided.
- Free cash flow was not reported.
- Dividend information was not reported.
- A quantitative fourth-quarter GAAP earnings, GAAP operating income, GAAP EPS, gross-margin, operating-expense or tax-rate outlook was not provided.
- Prior-period guidance was not provided, so no comparison of actual results with prior guidance is available.
- A quantitative year-over-year change was not printed for several reported financial statement line items, including gross profit, operating expenses, operating loss, EPS and nine-month metrics.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.